CHRISTOPHER SCOTT: Open Payments
NPI 1205591294 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 89 payments from 24 companies in 2025. Trend: 2023 $29 · 2024 $2,186 · 2025 $1,909
Food & beverage: $1,909
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 12 | $540 |
| Neurocrine BioSciences, Inc. | 13 | $232 |
| Teva Pharmaceuticals USA, Inc. | 13 | $189 |
| Lundbeck LLC | 6 | $104 |
| Eisai Inc. | 5 | $90 |
| UCB, Inc. | 5 | $89 |
| Merz Pharmaceuticals, LLC | 3 | $69 |
| PFIZER INC. | 4 | $65 |
| SK Life Science, Inc. | 4 | $62 |
| Neurelis, Inc. | 3 | $46 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, INGREZZA, AUSTEDO XR, VYEPTI, Leqembi, Xeomin, NURTEC ODT, Nayzilam.
Industry payments across OK — which companies pay providers there.
